Business Context and Reporting Period
This Form 8-K is a current report filed by The Clorox Company (CLX) on May 26, 2026, with the earliest event reported on that date. The filing addresses significant corporate governance changes regarding the Chief Executive Officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive leadership transitions and does not contain financial performance data.
Material Changes
- CEO Departure: Linda Rendle, Chair of the Board and CEO, has decided to step down for health reasons.
- Search Initiation: The Board has initiated a comprehensive CEO search process.
- Interim Role: Ms. Rendle will remain as Chair and CEO during the search and will serve in an advisory role following the appointment of her successor to ensure a smooth transition.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance or outlook. The primary risk disclosed is the leadership transition, though management intends to mitigate disruption through Ms. Rendle's continued involvement during the search and subsequent advisory period. A press release dated May 28, 2026, is attached as Exhibit 99.1 for further details.
Investor Verification Checklist
- Confirm the timeline for the CEO search process and expected appointment date.
- Review the attached press release (Exhibit 99.1) for specific details on the transition plan.
- Monitor future filings for the announcement of the new CEO and any changes to the Board composition.
- Verify if the CEO's health reasons impact any ongoing strategic initiatives or operational stability.